• 1. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 2. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 3. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 4. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 5. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275

Introduction to 3-(2-Propen-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine (CAS No. 857934-96-4)

3-(2-Propen-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine, identified by its CAS number 857934-96-4, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound belongs to the class of pyridine derivatives, which are widely recognized for their diverse biological activities and utility in drug development. The presence of both an alkene group and a boronic ester moiety makes this molecule particularly interesting for applications in cross-coupling reactions, which are fundamental to modern synthetic organic chemistry.

The structure of 3-(2-Propen-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine features a pyridine ring substituted at the 5-position with a boronic ester derived from tetramethylsiloxane, a stable and versatile protecting group for boronic acids. This substitution pattern enhances the compound's stability under various reaction conditions while maintaining its reactivity in Suzuki-Miyaura cross-coupling reactions. Such reactions are pivotal in constructing complex molecular architectures, particularly in the synthesis of biaryl compounds that are prevalent in many pharmaceuticals.

In recent years, the demand for efficient and scalable methods for constructing biaryl motifs has driven considerable research into boronic acid derivatives. The use of pinacol boronic esters, such as the one present in this compound, has become the gold standard due to their excellent handling properties and high coupling efficiency. The tetramethyl group in the boronic ester not only stabilizes the boron center against hydrolysis but also minimizes unwanted side reactions, making 3-(2-Propen-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine a preferred reagent in industrial and academic settings.

The pyridine core of this compound is a key pharmacophore that contributes to its potential biological activity. Pyridine derivatives are known to exhibit a wide range of biological effects, including antimicrobial, antiviral, and anticancer properties. The alkenyl group at the 3-position introduces additional conformational flexibility to the molecule, which can be exploited to optimize binding interactions with biological targets. This structural feature makes 3-(2-Propen-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine a valuable scaffold for medicinal chemists seeking to design novel therapeutic agents.

Recent advancements in computational chemistry have further enhanced our understanding of how structural modifications influence the reactivity and selectivity of pyridine-based compounds. Molecular modeling studies have shown that the presence of the tetramethyl group in the boronic ester enhances the electrophilicity of the boron center without significantly affecting other electronic properties of the molecule. This balance is critical for achieving high yields in cross-coupling reactions while maintaining compatibility with sensitive functional groups commonly found in drug candidates.

The utility of 3-(2-Propen-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine extends beyond its role as a synthetic intermediate. Researchers have begun exploring its potential as a building block for more complex materials with tailored electronic properties. For instance，the combination of a pyridine moiety with an alkenyl group has been shown to influence charge transport properties in organic semiconductors. This opens up possibilities for applications in optoelectronic devices such as organic light-emitting diodes (OLEDs) and organic photovoltaics (OPVs).

In conclusion,3-(2-propenylidene)-pyridinato ligands have been widely used as organometallic complexes that exhibit unique catalytic properties useful for asymmetric synthesis and C–C bond formation. The development of novel catalysts often requires careful tuning of ligand structure to achieve optimal reactivity and selectivity. This work highlights recent advances in designing highly effective organometallic catalysts based on chiral N-heterocyclic carbenes (NHCs) or related ligands. These catalysts represent powerful tools for constructing complex molecules with high enantioselectivity, and their continued development promises to significantly impact synthetic methodology across various disciplines. The increasing availability of sophisticated computational methods has further facilitated this process, allowing researchers to predict and rationalize catalytic behavior with unprecedented accuracy. Such progress underscores the importance of interdisciplinary collaboration between organic chemists, inorganic chemists, and computational scientists in advancing our understanding and application of transition-metal catalysis.

• 1627723-04-9(3-(tert-Butyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1430237-32-3(1-[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]ethanol)
• 1272356-97-4(2-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-ylacetonitrile)
• 2096336-91-1(3-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 2096342-36-6(5-Cyclopentylpyridine-3-boronic acid pinacol ester)
• 1220696-43-4(3-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1220696-49-0(3-ethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 2241875-23-8(3-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 2241875-31-8(3-(2-(methyl-d3)propyl-1,1,2,3,3,3-d6)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)
• 1171891-42-1(3-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine)